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SUMMARY – Th e aim of the study was to determine whether serum vitamin D level is lower in 
female patients with glaucoma as compared with control group. Th e mechanism by which vitamin D 
reduces intraocular pressure is not fully clarifi ed. Almost all tissues possess vitamin D receptor (VDR). 
Th e mice lacking VDR (VDR knockout mice) have greatly contributed to the understanding of the 
general vitamin D physiologic function. VDR has been found in some ganglion layer cells, external 
and internal nuclear layers of retina, and in retinal pigment epithelium, while VDR epitopes have also 
been found in the ciliary body epithelium, pointing to the role of this protein in eye physiology. Th e 
1,25(OH)2D3 modulates expression of the genes involved in the regulation of intraocular pressure in 
non-human primates. Extracellular matrix can be remodeled by 1,25(OH)2D3 treatment. Actin dis-
ruption can lead to cell morphology alteration, trabecular meshwork relaxation and intraocular pres-
sure reduction. Th is observational cross-sectional study included 90 female glaucoma subjects aged 
45-55 and 50 glaucoma free female subjects as control group. Results of a pilot study conducted in 20 
glaucoma subjects and 20 control subjects are presented below. All study subjects underwent history 
taking, complete ophthalmologic examination and serum vitamin D determination. Th e mean serum 
vitamin D level was 32.31 nmol/L in glaucoma patients and 64.17 nmol/L in control subjects. Serum 
vitamin D level was statistically signifi cantly lower in glaucoma patients as compared with control 
group (p<0.05).
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Introduction
Glaucoma is a multifactorial optic neuropathy cha-
racterized by acquired loss of optic nerve fi bers. Cur-
rent hypotheses on the potential pathogenic mecha-
nisms in the onset of glaucomatous optic neuropathy 
include exotoxic lesion due to excessive retinal gluta-
mate release, reduction in neuronal growth factor, per-
oxynitrite toxicity due to the increased activity of nitric 
monoxide synthetase, immune mediated optic nerve 
lesion, and oxidative stress.
Th ere are no generally accepted guidelines on ade-
quate vitamin D (1,25(OH)2D3) level. Serum vitamin 
D levels of 50-75 nmol/L (20-30 ng/mL) are consid-
ered as vitamin D insuffi  ciency, with adverse eff ects on 
bone mineral density and possibly on muscle and 
physical ability1-4. Th e levels <50 nmol/L are consid-
ered as vitamin D defi ciency and those <30 nmol/L as 
severe vitamin D defi ciency, whereas vitamin D levels 
<20 nmol/L cause serious impairment of bone me-
tabolism, i.e. rickets or osteomalacia, depending on 
age, as well as myopathy associated with physical in-
ability4,5. As a steroid hormone, vitamin D directly or 
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indirectly regulates 3% of the human genome func-
tion6. Favorable vitamin D eff ects have been demon-
strated in many diseases, e.g., in the prevention of 
heart attack and stroke, diabetes mellitus type 1 and 2, 
infections and chronic respiratory diseases, autoim-
mune diseases, etc. Vitamin D receptor (VDR) has 
been found in some ganglion layer cells, external and 
internal nuclear layers of retina, and in retinal pigment 
epithelium, while VDR epitopes have also been found 
in the ciliary body epithelium, pointing to the role of 
this protein in eye physiology. Vitamin D exerts auto-
crine and paracrine action via VDR6,7. Th e mechanism 
by which vitamin D reduces intraocular pressure (IOP) 
has not yet been fully clarifi ed. Th e 1,25(OH)2D3 
modulates expression of the genes involved in IOP 
regulation in non-human primates. Extracellular ma-
trix can be remodeled by 1,25(OH)2D3 treatment, 
resulting in increased fl uid fl ow along with reduced 
fl ow resistance by disruption of cellular adhesions and 
relaxation of contractile molecules8. Nitric oxide (NO), 
a free radical produced by vascular endothelium in-
duced by the endothelial nitric monoxide synthetase 
(eNOS) enzyme activity, is the key signaling molecule 
for local regulation of vascular tone. Some studies 
showed that increased NO levels increased the fl ow 
rate and thus reduced IOP9,10, whereas others report 
that the increased NO level led to peroxynitrite toxic-
ity and development of glaucomatous optic neuropa-
thy. Th e 1,25(OH)2D3 inhibits nitric oxide inducible 
synthetase (iNOS) expression and reduces NO pro-
duction in stimulated macrophages. Th e macrophage 
production of 1,25(OH)2D3 has protective eff ect on 
oxidative lesion caused by NO burst11.
Th e main hypotheses of the study were prompted 
by the vitamin D immunomodulatory action on the 
above mentioned parameters. A suffi  cient vitamin D 
status is associated with a lower risk of rheumatoid ar-
thritis, multiple sclerosis, diabetes mellitus type 1, au-
toimmune diseases and neurodegenerative diseases 
such as glaucoma. Despite the growing knowledge 
about the biological and clinical role of vitamin D, 
considerable prevalence of vitamin D defi ciency is re-
ported in the populations all over the world, including 
Croatia6,12,13. As VDR has been demonstrated in many 
structures of human eye, this type of research off ers an 
opportunity for studies at the molecular level and for a 
novel diagnostic and therapeutic approach in both sys-
temic and local vitamin D administration (autocrine 
and paracrine vitamin D action). If the results of this 
study indicate that glaucoma patients aged 45-55 have 
a decreased serum vitamin D level, it will provide a 
basis for additional clinical trials.
Patients and Methods
Patients
Th is pilot study included 20 female patients with 
open-angle glaucoma and 20 control female subjects. 
Blood samples for vitamin D determination were ob-
tained in late autumn and early spring. Women with 
any bone metabolism disorder, primary hyperparathy-
roidism, and those on vitamin D supplementation 
therapy were not included in the study. Excluded were 
also women with potentially altered serum vitamin D 
level for any reason (e.g., suntan studio, work in the 
open, diet, etc.).
Th e study will assess vitamin D eff ect on glaucoma 
as a disease using the following procedures: serum vi-
tamin D level will be determined in glaucoma patients 
and control group; serum vitamin D levels in these two 
groups will be compared and diff erences calculated; 
and association of serum vitamin D level with other 
study parameters of glaucoma development (IOP and 
optic nerve head lesions) will be assessed.
Methods
History data were obtained and complete ophthal-
mologic examination performed in study patients. 
Ophthalmologic examination included visual acuity 
testing by the subjective method using standard Snel-
len chart according to the international tables; anterior 
eye segment biomicroscopy on a biomicroscope 
(Haag-Streit BM 900, Switzerland); IOP measure-
ment on a Goldmann’s applanation tonometer (in mm 
Hg); fundus examination by direct or indirect ophthal-
moscopy; pachymetry (measurement of corneal thick-
ness, in μm); gonioscopy (chamber angle examination); 
and fi eld of vision analysis by computerized static pe-
rimetry according to Humphrey using SITA fast 24-2 
(Carl Zeiss Meditec, Dublin, Ca, USA) software.
Venous blood samples (≤5 mL) for determination 
of serum vitamin D levels were obtained in all study 
subjects. Total calcium (Ca) was determined on an Au 
680 autoanalyzer. Parathyroid hormone (PTH) and 
vitamin D in plasma were determined by the electro-
chemiluminescence method using respective reagents.
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Results were analyzed by nonparametric and para-
metric statistical methods (Student’s t-test and F-test), 
with the level of statistical signifi cance set at p<0.05 
and 95% confi dence interval (95% CI).
Results
Both study group and control group consisted of 
20 female subjects each. Th e mean age of glaucoma 
patients and control subjects was 51.8 and 49.45 years, 
respectively. Th e mean serum vitamin D level was 
32.31 nmol/L in glaucoma patients and 64.17 nmol/L 
in control subjects (Figs. 1 and 2). Th e mean Ca and 
PTH levels were within the normal range and served 
only to exclude primary hyperparathyroidism, which 
was not diagnosed in any of study subjects.
Visual acuity examined by use of Snellen chart was 
1.0 with or without correction in both groups. In glau-
coma patients, the mean corneal thickness measured 
by use of a pachymeter was 548.85 μm and 549.85 μm 
on the right and left eye, respectively. In control group, 
the respective fi gures were 552.60 μm and 551.90 μm 
(Fig. 3). Fundus lesions were found in 17 (85%) glau-
coma patients and three (15%) control subjects.
In glaucoma patients, the mean IOP value with 
therapy was 16.9 mm Hg and 17.2 mm Hg on the 
right and left eye, respectively, versus 15.85 mm Hg 
measured on both eyes in control group, yielding no 
statistically signifi cant between-group diff erence (Figs. 
4 and 5). Intraocular pressure higher than 21 mm Hg 
was not found in any of the control subjects. Patho-
logic fi eld of vision with glaucoma associated lesions 
was recorded in eight (40%) glaucoma patients and 
two (10%) control subjects.
Th e mean value of the optic nerve cup-to-disc (c/d) 
ratio measured on the right and left eye was 0.423 and 
0.417 in glaucoma patients versus 0.340 and 0.350 in 
control subjects, respectively; t-test yielded a statisti-
cally signifi cant between-group diff erence at the level 
of p<0.05.
Coeffi  cient of variation (CV) for vitamin D levels 
measured in glaucoma patients was higher compared 
to control subjects (32.32% vs. 28.33%). Th is relative 
variability was even more important considering that 
the mean serum vitamin D level was by 49.96% lower 
in glaucoma patients compared to control group. Upon 
calculating standard deviation of these two arithmetic 
means, followed by their comparison and calculation 
Fig. 1. Relationship of vitamin D levels in glaucoma 
patients and control subjects.
Fig. 2. Vitamin D levels 
measured in glaucoma group 
and control group.
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of common standard deviation of two arithmetic 
means, statistical signifi cance of the vitamin D stan-
dard deviations of the mean was calculated by F-test, 
which yielded a statistically signifi cant diff erence be-
tween these two arithmetic means at the level of 
p<0.05.
Discussion
Th e objective of this cross-sectional study was to 
determine whether serum vitamin D level is lower in 
female patients with glaucoma as compared with con-
trol group. Results of a pilot study that included 40 
female subjects (20 in glaucoma group and control 
group each) are reported. Glaucoma group consisted 
of female patients with open-angle glaucoma, while 
control group included glaucoma-free female subjects. 
Glaucoma subjects were recruited from the Glaucoma 
Registry of the Brod-Posavina County. Th e male to 
female ratio in the Glaucoma Registry is 30% to 70%. 
In contrast, most studies worldwide report no sex pre-
dominance for glaucoma (e.g., Baltimore, Beaver Dam, 
and Roscommon studies). Th e Barbados Eye Study 
found men to have a higher age-adjusted risk of glau-
coma than women, the Rotterdam study reports on a 
three-fold higher risk of glaucoma in men, whereas 
Dalby study found the risk of glaucoma to be higher in 
women14-18.
Our study subjects were aged 45-55. In this age 
group, vitamin D defi ciency generally is not as pro-
nounced as in >60 age group. A study conducted by 
Laktašić-Žerjavić et al. suggested vitamin D to vary 
Fig. 3. Pachymetry values on the right eye and left eye 
in glaucoma group and control group.
Fig. 4. Intraocular pressure values on the right eye 
and left eye in glaucoma group and control group.
Fig. 5. Multifunctional 
correlation of vitamin D 
and intraocular pressure 
for the right eye and left eye 
in glaucoma group and 
control group.
IOP-R =  intraocular pressure 
– right eye;
IOP-L =  intraocular pressure 
– left eye
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with age, sex, skin type, and season19. Advanced age, 
female sex, dark skin type, less sun exposure and poor 
dietary habits lacking vitamin D rich food have been 
associated with vitamin D defi ciency12,19-21. Th e 
25(OH)D level depends on its intradermal formation 
because dietary intake of vitamin D is low, and the ca-
pacity of vitamin D formation is weakened in the el-
derly due to skin thinning. Laktašić-Žerjavić et al. re-
port on the 25(OH)D level to decline most signifi -
cantly at the age 59 and the prevalence of all grades of 
vitamin D defi ciencies to rise signifi cantly with age. A 
very high prevalence (23.8%) of severe vitamin D defi -
ciency (25(OH)D <30 nmol/L) was recorded in fe-
male subjects aged >6521. Th erefore, on recruiting our 
study subjects according to age, we tended to avoid 
age-dependent vitamin D defi ciency.
Th e mean serum level of vitamin D was 32.31 
nmol/L in glaucoma patients and 64.17 nmol/L in 
control subjects, yielding a statistically signifi cant dif-
ference at the level of p<0.05. Th ere was no statisti-
cally signifi cant diff erence in the IOP values between 
glaucoma patients and control subjects (16.9 mm 
Hg/17.2 mm Hg on the right and left eye in glaucoma 
patients and 15.85 mm Hg on both eyes in control 
subjects), suggesting good therapeutic regimen in the 
former. Th ere was no statistically signifi cant between-
group diff erence in the mean pachymetry values 
(548.85/549.85 μm and 552.6/551.9 μm for the right/
left eye in glaucoma patients and control subjects, re-
spectively). Th us, there was no statistically signifi cant 
between-group diff erence in the eff ect on IOP either.
Th ere are only few studies on this subject. In 2012, 
Krefting et al. published their study on IOP regulation 
in non-human primates with topical application of 
1a,25 dihydroxy vitamin D(3) (1a25-(OH)2D3) or 
its analogs. Micro-fi eld analysis demonstrated that vi-
tamin D regulated the genes known to be involved in 
IOP regulation22. Yoo et al. were the fi rst to report on 
the association of vitamin D and primary open-angle 
glaucoma in 2014. Th eir study that included 6094 sub-
jects showed vitamin D defi ciency to be associated 
with a potential risk of open-angle glaucoma develop-
ment23. Several months later, however, Krefting et al. 
reported opposite fi ndings. Th eir study conducted in 
healthy subjects failed to demonstrate any association 
between serum vitamin D level and IOP. In subjects 
with low vitamin D level, vitamin D administration 
had no eff ect on IOP8.
Conclusion
Th e mean serum vitamin D level was lower in study 
subjects suff ering from glaucoma as compared to con-
trol subjects (32.31 nmol/L vs. 64.17 nmol/L), yield-
ing a statistically signifi cant between-group diff erence 
(p<0.05). Th is pilot study has justifi ed continuation of 
the research. If the pilot study results be confi rmed, 
then vitamin D may be considered a marker in the 
early diagnosis and prevention of glaucoma.
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Sažetak
POVEZANOST SERUMSKE KONCENTRACIJE VITAMINA D I GLAUKOMA KOD ŽENA
Ž. Vuković Arar, M. Knežević Praveček, B. Miškić, Z. Vatavuk, J. Vuković Rodriguez i S. Sekelj
Cilj istraživanja bio je utvrditi je li kod ispitanica oboljelih od glaukoma snižena serumska koncentracija vitamina D u 
odnosu na kontrolnu skupinu. Mehanizam kojim vitamin D snižava očni tlak nije jasno poznat. Gotovo sva tkiva posjeduju 
receptor za vitamin D (VDR). Velik doprinos razumijevanju globalne fi ziološke funkcije vitamina D dobiven je od miša 
kojemu nedostaje VDR (engl. knockout mice for VDR). VDR je pronađen u nekim stanicama ganglijskog sloja, u vanjskom i 
unutarnjem nuklearnom sloju mrežnice i u retinalnom pigmentnom epitelu. Epitopi za VDR su pronađeni i u epitelu cilijar-
nog tijela. To sve govori o važnosti tog proteina u fi ziologiji oka. 1,25 (OH)2D3 modulira ekspresiju gena koji su uključeni u 
regulaciju očnog tlaka u nehumanih primata. Nakon liječenja pomoću 1,25(OH)2D3 može se remodelirati ekstracelularni 
matriks. Disrupcija aktina može dovesti do promjene stanične morfologije, relaksacije trabekularne mreže i sniženja očnog 
tlaka. Provedeno je opažajno presječno istraživanje s kontrolnom skupinom. U istraživanje je bilo uključeno 90 ispitanica 
oboljelih od glaukoma u dobi od 45-55 godina i 50 ispitanica u kontrolnoj skupini. Prikazuju se rezultati probnog ispitivanja 
u 20 ispitanica oboljelih od glaukoma i isto toliko u kontrolnoj skupini. Ispitanicama je uzeta anamneza i kompletan oftal-
mološki status te je određen vitamin D u serumu. Koncentracija vitamina D u serumu ispitanica s glaukomom bila je 32,31 
nmol/L u odnosu na kontrolnu skupinu gdje je bila 64,17 nmol/L. U zaključku, kod ispitanica oboljelih od glaukoma bila je 
snižena serumska koncentracija vitamina D u odnosu na kontrolnu skupinu na statistički značajnoj razini od p<0,05.
Ključne riječi: Glaukom; Intraokularni tlak; Vitamin D; Receptori za kalcitriol
